Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease

författare

Jacqueline Barry

Mark A Vickers

publicerad i: British Journal of Haematology

utgivningsår: 2014-07-26

språk: engelska

huvudämne: Epstein-Barr-virus, Good Manufacturing Practice

Refererar artiklar 34

Datum

Titel

Författare

2014-03-20

The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak

David J. McLernon
2014-01-06

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus

Peter Hanlon, Lorna Aucott
2013-12-16

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

Barbara Pro, Luis E. Fayad, Catherine M Bollard, Cliona M Rooney, Malcolm K Brenner, Helen Heslop, Adrian P Gee, Carlos A Ramos, Oumar Diouf, Elizabeth J Shpall, George Carrum, Yasmin Hazrat, Jack Meng-Fen Su, Stephen Gottschalk, Vicky Torrano, Andrea M Sheehan
2013-09-20

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

Mikael Sundin, Jonas Mattsson, Markus Maeurer, Per Ljungman
2013-06-20

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Cliona M Rooney, Ann M Leen, Malcolm K Brenner, Helen Heslop, Robert A Krance, Alana A Kennedy-Nasser, Kathryn S Leung, Ulrike Gerdemann, Usha L Katari, Stephen Gottschalk, Jacqueline M Keirnan, Anastasia Papadopoulou
2013-05-06

EBV-positive diffuse large B-cell lymphoma of the elderly

Chi Young Ok
2013-04-22

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

Joseph H Antin, Catherine M Bollard, Cliona M Rooney, Ann M Leen, Malcolm K Brenner, Helen Heslop, Adrian P Gee, Elizabeth J Shpall, Bambi J Grilley
2013-04-09

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis

Alison Avenell, Lorna Aucott, Yahya H. Almohmeed, Mark A Vickers
2013-02-19

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score

Raphaël Porcher, Eric Alamartine, Nassim Kamar, Denis Glotz, Bruno Moulin, Yvon Lebranchu, Bruno Hurault de Ligny, Sophie Caillard, François Provôt, Jacques Dantal, Antoine Durrbach, Emmanuel Morelon, Valérie Moal, Claire Pouteil-Noble, Matthias Buchler, Marie-Noelle Peraldi, Olivier Toupance, Jean-Philippe Rerolle, Philippe Lang, Anne-Elisabeth Heng, Christiane Mousson, Joseph Rivalan, Marie-Christine Moal, Laetitia Albano, Jean-François Subra, Nacera Ouali, Pierre François Westeel, Michel Delahousse
2013-06-13

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe

Simone Cesaro, Miguel Angel Diaz, Rafael de la Camara, Franca Fagioli, Per Ljungman, Hermann Einsele, Jan Styczyński, Lidia Gil, Krzysztof Kałwak
2012-07-17

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

Catherine M Bollard, Cliona M Rooney, Helen Heslop
2012-02-05

EBV-associated lymphomas in adults

Mark Roschewski, Wyndham H. Wilson
2012-04-01

Epstein-Barr virus-associated gastric carcinoma: a newly defined entity
2012-07-17

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease.

Jonas Mattsson, Sofia Berglund, Jens Gertow, Per Ljungman
2011-12-02

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

Julie Teruya-Feldstein, Cyrus V Hedvat, Nancy A Kernan
2011-03-08

Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma

Iwona Wlodarska, Stefania Pittaluga, Elaine Jaffe, Mark Raffeld, Girish Venkataraman, Stefan D Dojcinov, Jeffrey A Schrager
2010-09-08

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

Mikhail Doubrovin
2010-10-01

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

Catherine M Bollard, Cliona M Rooney, Ann M Leen, Malcolm K Brenner, Helen Heslop, Barbara Savoldo, Adrian P Gee, Conrad Russell Cruz, Gianpietro Dotti, Stephen Gottschalk, Vicky Torrano, James A Arce, Chrystal U Louis, Patrick J Hanley
2010-07-01

Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up
2010-01-26

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

Andreas Moosmann, Josef Mautner
2009-10-30

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Julia L. Hurwitz, Catherine M Bollard, Cliona M Rooney, Malcolm K Brenner, Helen Heslop, Jack Meng-Fen Su, Martin Pule, Persis J Amrolia, Karen Slobod
2009-09-01

How I treat EBV lymphoproliferation

Helen Heslop
2009-05-14

CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells

Jianmin Zuo
2009-06-01

Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition

Erik Hooijberg, Kees Melief, Ekaterina S. Jordanova, R Maarten Egeler, Arjan Lankester, Marco W Schilham, Dagmar Berghuis, Susy J Santos
2009-10-01

Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.

George Mazariegos, Michael Green
2007-04-27

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Anthony Swerdlow
2007-01-01

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus

Delphine Sauce
2006-12-01

Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review
2004-07-01

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases
2002-08-01

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

Anthony Swerdlow
2002-09-01

Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma

Vishnu V B Reddy
2001-08-01

Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity.

Edward L Nelson

Artikel - wd:Q33456742

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer